200 Boston Avenue
President & CEO
Seventh Sense Biosystems, Inc.
Seventh Sense Biosystems is developing and commercializing an array of products based on the company's proprietary Touch Activated Phlebotomy (TAP™) painless blood collection platform, with an initial focus on enabling important diagnostic testing at the point of care by reducing the discomfort, anxiety and hassle of blood sample collection that can inhibit and sometimes prevent patients from undergoing blood tests and receiving appropriate care.
Harry Wilcox is on the Board of Directors.